Lieff Cabraser Partner Rachel Geman Named Class Counsel for Medical Monitoring Class in Valsartan Products Liability Litigation

On February 8, 2023, Judge Robert B. Kugler of the U.S. District Court for the District of New Jersey appointed Lieff Cabraser partner Rachel Geman as one of Class Counsel for the Medical Monitoring class in In re Valsartan, Losartan, and Irbesartan Products Liability Litigation, No. 19-2875 (RBK/SAK).

2023-02-10T00:04:59+00:00February 9th, 2023|Prescription Drug Injuries|

Complaint Seeking Medical Monitoring, Economic Reimbursement, and Damages for Personal Injuries Filed in Valsartan Products Liability MDL

On June 17, 2019, Lieff Cabraser and co-counsel filed a Consolidated Amended Class Action Complaint in the consumer fraud litigation against Teva, Major Pharmaceuticals, and Solco Healthcare based on reports that huge amounts of the hypertension drug Valsartan, the generic equivalent of the hypertension drug Diovan, were contaminated with a carcinogen called NDMA. This contamination

2019-06-18T11:16:33+00:00June 18th, 2019|Consumer Fraud, Personal Injury|